Cachet Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Cash & Equivalents	2,621	2,559	2,223	2,885	2,184	2,338
Trading Asset Securities	0.06	5.14	0.17	0.14	0.16	0.23
Cash & Short-Term Investments	2,621	2,564	2,223	2,886	2,184	2,338
Cash Growth	17.52%	15.32%	-22.95%	32.14%	-6.61%	15.85%
Accounts Receivable	5,491	6,054	7,171	9,205	8,885	8,039
Other Receivables	57.26	80.26	82.7	331.79	390.51	113.61
Receivables	5,548	6,134	7,254	9,537	9,276	8,153
Inventory	2,102	2,465	2,739	2,562	2,692	2,185
Other Current Assets	463.67	671.72	788.03	646.38	843.66	609.02
Total Current Assets	10,735	11,835	13,005	15,631	14,996	13,285
Property, Plant & Equipment	368.5	404.33	465.38	679.74	735.93	850.26
Long-Term Investments	1.89	1.89	1.87	1.74	2.44	2.53
Goodwill	346.51	346.51	395.45	475.86	515.92	562.38
Other Intangible Assets	24.68	24.96	24.45	35.58	35.79	36.58
Long-Term Accounts Receivable	-	-	3.56	27.32	33.56	-
Long-Term Deferred Tax Assets	75.28	72.51	73.03	92.97	68.15	52.57
Long-Term Deferred Charges	58.51	57.8	63.45	171	144.35	122.8
Other Long-Term Assets	5.48	5.61	5.85	6.1	24.89	25.14
Total Assets	11,616	12,748	14,038	17,121	16,557	14,938

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Accounts Payable	3,525	4,216	4,474	5,858	5,320	4,442
Accrued Expenses	60.9	147.78	160.59	71.42	53.81	62.23
Short-Term Debt	1,428	1,789	2,677	3,882	4,112	4,002
Current Portion of Leases	-	36.7	58.17	54.89	49.7	58.16
Current Income Taxes Payable	53.44	58.54	42.93	82.2	71.29	60.31
Current Unearned Revenue	123.77	147.03	186.31	433.63	291.82	309.06
Other Current Liabilities	339.09	371.43	314.32	467.01	517.26	87.43
Total Current Liabilities	5,557	6,767	7,914	10,849	10,415	9,022
Long-Term Leases	93.86	104.37	130.09	175.95	208.76	229.24
Long-Term Deferred Tax Liabilities	1.37	1.39	0.76	4.3	11.24	29.95
Total Liabilities	5,653	6,873	8,045	11,029	10,635	9,281

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Common Stock	291.71	291.71	291.71	291.71	291.71	291.71
Additional Paid-In Capital	1,292	1,292	1,292	1,291	1,291	1,288
Retained Earnings	2,855	2,768	2,706	2,658	2,495	2,306
Total Common Equity	4,439	4,352	4,290	4,241	4,078	3,887
Minority Interest	1,525	1,524	1,703	1,851	1,844	1,770
Shareholders' Equity	5,964	5,876	5,993	6,092	5,922	5,657
Total Liabilities & Equity	11,616	12,748	14,038	17,121	16,557	14,938

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Total Debt	1,549	1,930	2,866	4,113	4,370	4,290
Net Cash (Debt)	1,072	633.82	-642.28	-1,227	-2,186	-1,951
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	3.66	2.16	-2.19	-4.22	-7.51	-6.67
Filing Date Shares Outstanding	285.45	291.71	291.71	291.71	291.71	291.71
Total Common Shares Outstanding	285.45	291.71	291.71	291.71	291.71	291.71
Working Capital	5,178	5,068	5,091	4,781	4,581	4,263
Book Value Per Share	15.55	14.92	14.71	14.54	13.98	13.32
Tangible Book Value	4,067	3,980	3,870	3,729	3,526	3,288
Tangible Book Value Per Share	14.25	13.64	13.27	12.78	12.09	11.27
Buildings	-	273.07	273.07	273.07	273.07	273.07
Machinery	-	247.36	247.57	882.53	797.4	723.89
Construction In Progress	-	3.18	1.09	-	1.56	5.08